Dr. Lim Say Wan

Dr. Lim Say Wan is a senior consultant cardiologist at Gleneagles Kuala Lumpur, one of Malaysia's most prestigious private hospitals and a leading hub for medical tourism in Southeast Asia. With 25 years of cardiology practice, he has established himself as one of Malaysia's experienced interventional cardiologists, managing both complex acute cardiac cases and chronic heart disease in a diverse patient population.

Malaysia carries a significant cardiovascular disease burden, with coronary heart disease representing the leading cause of death. Dr. Lim's practice encompasses the full spectrum of modern cardiology — from preventive risk factor management and non-invasive diagnostic workup through to cardiac catheterization and percutaneous coronary intervention (PCI) for acute and stable coronary artery disease.

His multilingual capability — consulting in English, Malay, and Mandarin — allows him to serve Kuala Lumpur's ethnically diverse patient population as well as the large numbers of international patients from Indonesia, Singapore, Brunei, and beyond who choose Gleneagles KL for cardiac care. He is a member of the National Heart Association of Malaysia and the Asian Pacific Society of Cardiology.

Dr. Lim completed his MBBS before undertaking postgraduate training in internal medicine and cardiology, obtaining Membership of the Royal College of Physicians (MRCP, UK) — a globally respected postgraduate medical qualification. He completed a subspecialty fellowship in interventional cardiology with training in cardiac catheterization laboratory technique, coronary angioplasty, and stent placement, giving him the skills to perform the full range of coronary interventional procedures. He has participated in advanced echocardiography training and regularly attends the National Heart Association of Malaysia Annual Scientific Meeting and Asian Pacific Society of Cardiology congresses.

Dr. Lim's interventional cardiology practice includes diagnostic coronary angiography, percutaneous coronary intervention (balloon angioplasty, drug-eluting stent implantation), and cardiac catheterization for both diagnostic and therapeutic purposes. He manages STEMI (ST-elevation myocardial infarction) via primary PCI in Gleneagles KL's 24-hour cardiac catheterization laboratory.

His non-invasive practice encompasses transthoracic and stress echocardiography for assessment of cardiac function, valvular disease, and cardiomyopathy; exercise and pharmacological stress testing; and Holter monitoring for arrhythmia detection. He performs pacemaker implantation for symptomatic bradyarrhythmias and manages heart failure, atrial fibrillation, and complex valvular disease with medical and procedural therapy.

Gleneagles Kuala Lumpur is accredited by the Malaysian Society for Quality in Health and is a leading destination for patients from Indonesia, Brunei, Myanmar, and other regional countries seeking high-quality cardiac care. The hospital's international patient centre provides assistance with cost estimates, visa support letters, accommodation coordination, and insurance claim management. Dr. Lim consults in English, Malay, and Mandarin. Video consultations are available for initial cardiac assessment and follow-up after discharge. Malaysia's combination of internationally trained specialists, modern cardiac facilities, and competitive pricing (substantially below Singapore prices) makes Gleneagles KL a highly attractive option for regional cardiac patients.

Dr. Lim is a member of the National Heart Association of Malaysia and the Asian Pacific Society of Cardiology, through which he participates in regional cardiac care quality initiatives and continuing education programmes. He has received clinical recognition from Gleneagles Kuala Lumpur for performance in interventional cardiology. Over his 25-year career, he has trained cardiology registrars and junior doctors in catheterization laboratory technique and has contributed to the development of cardiac care standards at Gleneagles KL. He participates in the Malaysia Acute Coronary Syndrome Registry (MACS) — a national database tracking cardiac outcomes.